Search This Blog

Thursday, November 7, 2019

IGM Biosciences reports Q3 results

IGM Biosciences (NASDAQ:IGMS): Q3 GAAP EPS of -$2.41.
Cash and investments of $251.35M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)